A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
IsraelRecruitingPHASE1, PHASE2
Conditions
Cervical Cancer · Gastric/Gastroesophageal Junction Adenocarcinoma · Microsatellite Stable Colorectal Cancer · Non-Small-Cell Lung Cancer · Squamous Cell Carcinoma of Head and Neck · Carcinoma, Renal Cell · Urothelial Carcinoma · Pancreatic Adenocarcinoma · Melanoma · Ovarian Neoplasms · Triple Negative Breast Neoplasms
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
- Community Cancer Institute, Clovis, California, United States
- USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States
- Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States
- University of Iowa, Iowa City, Iowa, United States
- John Theurer Cancer Center, Hackensack, New Jersey, United States
- Local Institution - 0006, New York, New York, United States
- Local Institution - 0002, New York, New York, United States
- Providence Cancer Center Oncology and Hematology Care- Eastside, Portland, Oregon, United States
- Local Institution - 0063, Nashville, Tennessee, United States
- Vanderbilt University Medical Center, Nashville, Tennessee, United States
- Houston Methodist Hospital, Houston, Texas, United States
- Blacktown Hospital, Blacktown, New South Wales, Australia
- Liverpool Hospital, Liverpool, New South Wales, Australia
- Princess Alexandra Hospital, Brisbane, Queensland, Australia
- Cabrini Hospital - Malvern, Malvern, Victoria, Australia
- St Vincent's Hospital, Melbourne, Victoria, Australia
- One Clinical Research, Nedlands, Western Australia, Australia
- Cross Cancer Institute, Edmonton, Alberta, Canada
- BC Cancer Vancouver, Vancouver, British Columbia, Canada
- Hamilton Health Sciences-Juravinski Cancer Centre, Hamilton, Ontario, Canada
- Local Institution - 0009, Toronto, Ontario, Canada
- Centre Hospitalier de luniversite de Montreal, Montreal, Quebec, Canada
- The Ottawa Hospital Cancer Centre, Ottawa, Canada
- Local Institution - 0067, Beijing, Beijing Municipality, China
- Universitaetsklinikum Ulm, Ulm, Baden-Wurttemberg, Germany
- Universitaetsklinikum Carl Gustav Carus Dresden-University Cancer Center Early Clinical Trial Unit, Dresden, Germany
- Universitaetsklinikum Essen, Essen, Germany
- Universitatsklinikum Frankfurt, Frankfurt, Germany
- Universitaetsklinikum Wuerzburg, Würzburg, Germany
- Rabin Medical Center, Petah Tikva, Central District, Israel
- Local Institution - 0035, Ramat Gan, Central District, Israel
- Sheba Medical Center, Ramat Gan, Central District, Israel
- Rambam Health Care Campus, Haifa, Northern District, Israel
- Sourasky Medical Center, Tel Aviv, Tell Abīb, Israel
- Humanitas, Rozzano, Milano, Italy
- Istituto di Candiolo IRCCS - Fondazione del Piemonte per l'Oncologia, Candiolo, Torino, Italy
- Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1, Milan, Italy
- Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Università Cattolica del Sacro Cuore, Roma, Italy
- ospedale le scotte-U.O.C. Immunoterapia Oncologica, Siena, Italy
- National Cancer Center Hospital East, Kashiwa, Chiba, Japan
- Hospital Universitario Virgen de la Victoria, Málaga, Andalusia, Spain
- Institut Catalan d Oncologia (ICO) - Badalona, Badalona, Barcelona [Barcelona], Spain
- Hospital Universitari Vall d'Hebron, Barcelona, Barcelona [Barcelona], Spain
- Hospital Universitario 12 de Octubre, Madrid, Madrid, Comunidad de, Spain
- Hospital Universitario Fundación Jiménez Díaz-START Madrid-FJD, Madrid, Spain
- Centro Integral Oncologico Clara Campal-Hospital HM Universitario Sanchinarro-START Madrid-CIOCC, Madrid, Spain
- Clinica Universidad de Navarra-oNCOLOGY, Pamplona, Spain